Jan 19, 2023 / 05:30PM GMT
Mayank Mamtani - B. Riley Securities, Inc., Research Division - MD, Senior Biotech Research Analyst & Group Head of Healthcare
Good morning, and good morning for folks here on the West Coast. So we'll get started with our next company in Gritstone bio, where we have with us Co-Founder, President and CEO, Andrew Allen. Thanks, Andrew, and the audience here for being part of B. Riley Oncology Conference.
This is Mayank Mamtani, one of the senior biotic analysts in the health care team. At any point during the fireside chat, feel free to email me questions at [email protected].
Andrew, maybe to get us started here at the highest level for folks who are less familiar with the Gritstone bio story, would love to hear about your differentiated vaccine platform that you've been working on across cancer and infectious diseases, and some of the development capabilities that you've kind of developed over the years, Andrew?
Andrew R. Allen - Gritstone bio, Inc. - Co-Founder, President, CEO & Director
Thanks, Mayank. So first of all, thanks
Gritstone bio Inc at B Riley Securities Oncology Conference (Virtual) Transcript
Jan 19, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers